Records containing: Myeloma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-11-26Liquid Biopsy Evaluation and Repository Development at Princess Margaret
-
CLINICAL_TRIALS study record update · 2025-11-05Pilot Study T Cell Depletion in the Setting of Autologous Stem Cell Transplantation for Patients With Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-10-21Phase I Study of Adoptive Transfer of Autologous T Lymphocytes Engrafted With a Chimeric Antigen Receptor Targeting the Kappa Light Chain of Immunoglobulin Expressed in Patients With CLL, B-Cell Lymphoma or Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-10-07Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy (Start Ig)
-
CLINICAL_TRIALS study record update · 2025-10-07Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy (Dose-Ig)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-10-07A Randomised Platform Trial Evaluating the Role of Interventions to Prevent Infection in Patients With Acquired Hypogammaglobulinemia Secondary to Haematological Malignancies - RATIONAL-PT (Core)
-
CLINICAL_TRIALS study record update · 2025-10-07Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy (Stop-Ig)
-
CLINICAL_TRIALS study record update · 2025-10-03A Study of the Bortezomib, Lenalidomide, and Dexamethasone (VRD) Regimen for the Treatment of Newly Diagnosed Multiple Myeloma Patients
-
CLINICAL_TRIALS study record update · 2025-09-17Supportive Transfusion Program for Patients With Hematologic Malignancies: A Cluster Randomized Trial
-
CLINICAL_TRIALS study record update · 2025-09-10A Pilot Study to Determine the Safety and Efficacy of Repeated Hyperbaric Oxygen Therapy in Multiple Myeloma Patients Undergoing High-Dose Therapy and Autologous Stem/Progenitor Transplantation
-
CLINICAL_TRIALS study record update · 2025-08-19The Development and Pilot Testing of a New Magnetic Resonance (MR) Imaging Protocol to Quantify Both Myeloma Disease Burden and Associated Bone Loss
-
CLINICAL_TRIALS study record update · 2025-08-13Evaluation of the Use of an Oral Direct Anti-Xa Anticoagulant, Apixaban, in Prevention of Venous Thromboembolic Disease in Patients Treated With IMiDs During Myeloma : a Pilot Study
-
CLINICAL_TRIALS study record update · 2025-08-08KRd Consolidation in Myeloma Patients With a Positive PET-CT After Standard First Line Treatment. A Phase II Study
-
CLINICAL_TRIALS study record update · 2025-08-06A Prospective, Single-Arm, Single-Center, Phase II Clinical Trial of Siltuximab for Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity After CAR-T Treatment in Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-08-05Pilot Study to Develop a Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing Blood and Marrow Transplantation
-
CLINICAL_TRIALS study record update · 2025-07-29PROactive Evaluation of Function to Avoid CardioToxicity
-
CLINICAL_TRIALS study record update · 2025-07-28Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia
-
CLINICAL_TRIALS study record update · 2025-07-11Pilot Trial of Telehealth Music Therapy for Cognitive Dysfunction in Hematologic Cancer Survivors (PRELUDE)
-
CLINICAL_TRIALS study record update · 2025-07-01UARK 2008-03 Phase II Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy (No Prior Transplant)
-
CLINICAL_TRIALS study record update · 2025-03-27Dose-reduced Generic Plerixafor Efficacy of Autologous Hematopoietic Stem Cell Transplantation in Patients With Lymphoma and Myeloma
-
CLINICAL_TRIALS study record update · 2024-11-19Bio-monitoring of Newly Diagnosed Multiple Myeloma Patients Receiving Induction Chemotherapy Using Mobile Wearable Health Devices
-
CLINICAL_TRIALS study record update · 2024-09-25Geriatric-assessment-guided Interventions to Address Functional Deficits in Older Adults Undergoing Treatment for Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2024-09-19Phase I/II Study of Ixazomib in Combination with Pomalidomide, Clarithromycin and Dexamethasone (PiC-D) in Patients with Double Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2024-09-19A PHASE 1B/2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, PHARMACODYNAMICS, AND EFFICACY OF ELRANATAMAB (PF-06863135) IN CHINESE PARTICIPANTS WITH MULTIPLE MYELOMA WHO ARE REFRACTORY TO AT LEAST ONE PROTEASOME INHIBITOR, ONE IMMUNOMODULATORY DRUG AND ONE ANTI-CD38 ANTIBODY (TRIPLE-CLASS REFRACTORY MM)
-
CLINICAL_TRIALS study record update · 2024-09-05Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma